Cancer Vaccine ImMucin Shows Promising Results After Clinical Trial; May Work On 90% Of All Cancer Types Researchers in Israel have taken a truly innovative approach toward treating cancer in their attempt to harness the body’s own immune system to fight off the disease. Based on clinical trials for a cancer vaccine, called ImMucin, results […]
Vitals Key clinical point: The investigational anti-CD38 antibodies SAR650984 and daratumumab in combination with standard regimens were highly active in untreated and relapsed/refractory multiple myeloma. Major finding: Overall response rates were 58% in patients treated with SAR650984, and 100% and 50%, respectively, in newly diagnosed and relapsed patients given daratumumab. Data source: Two phase Ib studies in […]
